sfondo pallini

News
& Media

Below you can fin all our press releases and company info

Order by:

Taking part in the First International Campaign Raising Awareness for Ataxia ...

December 04, 2020

Read more

EryDel Appoints Dr Esin Kosal, PhD,as Senior Vice President, Global Regulatory ...

November 30, 2020

Read more

EryDel Appoints Carlo Incerti, MD, as Chairman of its Board of ...

November 20, 2020

Read more

International Ataxia Awareness Day (IAAD)

September 25, 2020

Read more

EU support for Italian biotech’s red blood cell technology to treat ...

August 06, 2020

Read more

EryDel Announces Completion of Patient Enrollment in Phase 3 ATTeST Trial ...

April 14, 2020

Read more

Rare Disease Day

February 29, 2020

Read more

20th ANNUAL INTERNATIONAL ATAXIA AWARENESS DAY

September 25, 2019

Read more

EryDel to present at
Italian A-T Association Family Weekend

September 18, 2019

Read more

EryDel to Present at A-T
Society Family Weekend

July 20, 2019

Read more

Luca Benatti, President and Chief Executive Officer, and Stan Musial, Chief ...

June 10, 2019

Read more

EryDel Appoints Alyssa Wyant as Senior Vice President, Regulatory Affairs.

January 08, 2019

Read more

EryDel Appoints Stan Musial as Chief Financial Officer

November 12, 2018

Read more

EryDel appoints Ronan Gannon as Chief Commericial Officer

October 15, 2018

Read more

EryDel-Orphan Technologies signing a licensing and supply agreement

June 04, 2018

Read more

EryDel to present at the UBS Global Healthcare Conference 2018

May 14, 2018

Read more

EryDel Raises Euro 26.5 Million in Financing

April 24, 2018

Read more

EryDel Appoints Guenter R Janhofer, MD, as Chief Medical Officer

February 16, 2018

Read more

EryDel announced the initiation of the Ataxia Telangiectasia Trial with the ...

March 06, 2017

Read more

EryDel Consortium gains Euro 6 million Funding for development of EDS ...

January 07, 2016

Read more

Long term benefit of erytrocyte-delivered dexamathasone in Ataxia Telangiectasia

May 19, 2015

Read more

EryDel expands Series B financing to 29.5M

May 11, 2015

Read more

Phase II results in Ataxia Telangiectasia published in Orphanet Journal of ...

February 20, 2014

Read more

Show all